Procter & Gamble Company (The) $PG Stock Sold by Candriam S.C.A.

Candriam S.C.A. cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 10.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 590,173 shares of the company’s stock after selling 66,250 shares during the quarter. Candriam S.C.A.’s holdings in Procter & Gamble were worth $86,054,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in PG. BlackRock Inc. acquired a new position in Procter & Gamble in the second quarter valued at $27,862,105,000. Bank of America Corp DE purchased a new stake in Procter & Gamble during the second quarter valued at about $3,850,628,000. Bank of New York Mellon Corp acquired a new stake in Procter & Gamble during the second quarter worth about $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Procter & Gamble during the second quarter worth about $1,480,650,000. Finally, Corient Private Wealth LP purchased a new position in shares of Procter & Gamble in the 2nd quarter worth about $335,908,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 1.1%

NYSE PG opened at $165.31 on Friday. The company’s fifty day simple moving average is $152.01 and its 200-day simple moving average is $149.43. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.52. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. The stock has a market cap of $383.15 billion, a P/E ratio of 24.90, a PEG ratio of 4.07 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The business had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. During the same period last year, the business earned $1.99 EPS. The business’s revenue was up 4.0% on a year-over-year basis. Equities research analysts predict that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be given a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is presently 65.51%.

Insider Buying and Selling

In other news, CEO Shailesh Jejurikar sold 35,000 shares of the firm’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the sale, the chief executive officer directly owned 55,391 shares in the company, valued at $9,033,718.19. This trade represents a 38.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Matthew Janzaruk sold 9,479 shares of Procter & Gamble stock in a transaction dated Tuesday, November 3rd. The stock was sold at an average price of $163.00, for a total value of $1,545,077.00. Following the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at approximately $207,173. The trade was a 88.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 161,709 shares of company stock worth $26,244,058 over the last quarter. Company insiders own 0.23% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G has raised its dividend for 70 consecutive years. Its quarterly payout is about $1.09 per share, equivalent to a roughly 2.6% yield, supporting the stock’s appeal to income-focused investors. Article: P&G dividend history and yield
• Positive Sentiment: Recent coverage points to investor interest in consumer-staples stocks as technology shares weaken. P&G may benefit from its defensive profile and dividend reputation. Article: Consumer staples rotation
• Neutral Sentiment: Zacks Research made mixed earnings-estimate changes: it lowered several forecasts for 2027 and 2028, while modestly raising some later-period estimates. The mixed revisions offer no clear overall change in the longer-term outlook. Procter & Gamble analyst estimates
• Neutral Sentiment: Management will discuss strategy and P&G’s long-term transformation at an Investor Day webcast on November 19; investors may look for updates on growth and execution. Article: P&G Investor Day webcast
• Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct stake by roughly 34%. The sale may concern investors, although insider transactions alone do not establish a change in the company’s prospects. Article: CFO share sale

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Wells Fargo & Company lifted their price objective on Procter & Gamble from $164.00 to $180.00 and gave the company an “overweight” rating in a research note on Friday, October 23rd. BNP Paribas Exane increased their target price on shares of Procter & Gamble from $177.00 to $189.00 and gave the stock an “outperform” rating in a research report on Friday, October 23rd. Argus lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. Morgan Stanley lifted their price target on shares of Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a research report on Friday, October 23rd. Finally, UBS Group set a $166.00 price objective on shares of Procter & Gamble in a research note on Friday, October 23rd. Fifteen analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $170.57.

Procter & Gamble Company Profile